Sodium Glucose Cotransporter 2 Inhibition and the Visualization of Kidney Hemodynamics

被引：6
作者：
Wanner, Christoph [1 ]
机构：
[1] Univ Hosp Wurzburg, Dept Med, Div Nephrol, Oberdurrbacherstr 6, D-97080 Wurzburg, Germany
来源：
CIRCULATION | 2019年 / 140卷 / 04期
关键词：
Editorials; diabetes mellitus; type; 2; glomerular filtration rate; hemodynamics; microscopy; fluorescence; multiphoton; sodium glucose transporter 2 inhibitors; EMPAGLIFLOZIN; OUTCOMES; DISEASE;
D O I：
10.1161/CIRCULATIONAHA.119.040326
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：316 / 318
页数：3
相关论文
共 50 条
  • [21] Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Diabetes Mellitus and Chronic Kidney Disease: Turning the Page
    Plutzky, Jorge
    Bakris, George
    CIRCULATION, 2018, 137 (02) : 130 - 133
  • [22] Exposure-Response Analysis of the Sodium-Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes
    van der Hoek, Sjoukje
    Koomen, Jeroen V. V.
    van Bommel, Erik J. M.
    Mosterd, Charlotte M. M.
    Scholtes, Rosalie A. A.
    Hesp, Anne C. C.
    Stevens, Jasper
    van Raalte, Daniel H. H.
    Heerspink, Hiddo J. L.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [23] Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence
    Schechter, Meir
    Melzer-Cohen, Cheli
    Rozenberg, Aliza
    Yanuv, Ilan
    Chodick, Gabriel
    Karasik, Avraham
    Kosiborod, Mikhail
    Mosenzon, Ofri
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [24] Inhibition of Sodium-Glucose Cotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease
    Rodriguez, Daniel
    Kapoor, Sarika
    Edenhofer, Ilka
    Segerer, Stephan
    Riwanto, Meliana
    Kipar, Anja
    Yang, Ming
    Mei, Changlin
    Wuethrich, Rudolf P.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2015, 40 (06) : 638 - 647
  • [25] Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure
    Shah, Kevin S.
    Fang, James C.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 109 - 120
  • [26] Lipid effects of sodium-glucose cotransporter 2 inhibitors
    Lazarte, Julieta
    Kanagalingam, Tharsan
    Hegele, Robert A.
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (03) : 183 - 190
  • [27] Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
    Castoldi, Giovanna
    Carletti, Raffaella
    Ippolito, Silvia
    Colzani, Massimiliano
    Barzaghi, Francesca
    Stella, Andrea
    Zerbini, Gianpaolo
    Perseghin, Gianluca
    Zatti, Giovanni
    di Gioia, Cira R. T.
    ACTA DIABETOLOGICA, 2021, 58 (08) : 1059 - 1070
  • [28] Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease
    Rastogi, Anjay
    Januzzi, James L., Jr.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (08)
  • [29] Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
    Sanjay Kalra
    Vikram Singh
    Dinesh Nagrale
    Advances in Therapy, 2016, 33 : 1502 - 1518
  • [30] Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Outcomes across the Spectrum of Kidney Disease A Systematic Review and Meta-Analysis
    Spiazzi, Bernardo F.
    Piccoli, Giovana F.
    Wayerbacher, Laura F.
    Lubianca, Joao Pedro N.
    Scalco, Bruno G.
    Scheffler, Mariana H.
    Fraga, Bruna L.
    Colpani, Veronica
    Gerchman, Fernando
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 20 (01): : 39 - 49
12345